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 Hammond, Kelley Grace. M.S. The University of Memphis. May 2010. Central versus peripheral 
manifestations of neuromuscular force production in persons with Parkinson’s disease. Major Professor: 
Brian K. Schilling, Ph.D. 
Bradykinesia and reduced neuromuscular force exist in Parkinson’s disease (PD). Percutaneous 
electrical stimulation (PES) has been used to evaluate central versus peripheral manifestations of 
neuromuscular strength in healthy, aging, and athletic populations, but this method has not previously been 
used in PD. This pilot study used PES of the quadriceps femoris to identify central and peripheral 
activation in persons with PD (n = 7) and neurologically healthy controls (n = 6). Maximal voluntary rate 
of force development (PD = 2544N/s ± 1183, control = 4599N/s ± 1077; P = 0.008) and the rate of force 
development ratio (RFDR; PD = 0.45 ± 0.15, control = 0.80 ± 0.20; P = 0.004) were significantly (P < 
0.05) lower in the PD group compared to controls. No other significant differences were found between 
groups. This study was the first to quantify the central deficits caused by PD which bring about reduced 
neuromuscular rate of force development. 
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INTRODUCTION 
Parkinson’s disease (PD) is a central nervous system disorder that results in several debilitating 
symptoms. Among these symptoms are reduced neuromuscular strength and bradykinesia (slowness of 
movement)1. These difficulties with motor control evolve deep within the brain in the substantia nigra, 
where dopaminergic neurons are killed by the disease. Because dopamine is a neurotransmitter that 
regulates movement, persons with PD are unable to control movement via signaling from the brain to the 
body’s periphery in the same manner as healthy persons do. Symptoms include, but are not limited to, 
tremor of the hands, arms, legs, jaw, and face, rigidity (stiffness) of the limbs and trunk, bradykinesia, and 
postural instability (impaired balance and coordination)2. Parkinson’s disease is chronic and progressive. 
More Americans (~1 million) suffer from PD than Amyotrophic Lateral Sclerosis (Lou Gehrig’s disease), 
multiple sclerosis, and muscular dystrophy combined, and the yearly cost of treatment and loss of ability to 
work is estimated at 25 billion dollars in the United States alone3.  
Most studies comparing persons with PD to neurologically healthy, age-matched individuals have 
reported reduced strength in PD4-13. This supports the presumption that decreased strength is caused by the 
disease6. Corcos et al.7 and Nallegowda et al.4 reported reduced voluntary strength and rate of force 
development (RFD) following withdrawal from antiparkinson medication, which suggests that this 
weakness and reduction in RFD is a direct result of the disease, and that at least part of the weakness is 
central in nature. While neurologically healthy persons typically take less than one second to achieve peak 
force, PD patients with moderate bradykinesia can take 3-4 seconds4,7. Further, Corcos et al.7 concluded 
that changes in strength correlate significantly with changes in contraction rate.  
Central and peripheral effects of the disease include decreases and irregularities in  motoneuron 
firing rates and deficits in muscular strength5,14. Superimposed electrical stimulation is an effective method 
of evaluating and quantifying voluntary versus involuntary muscle activity15-17, but has not been used in 
PD. By stimulating a relaxed muscle, the maximal involuntary rate of force development (MIRFD) can be 
identified and used to estimate the aptitude of the muscle’s contractility without central input. If this evoked 
twitch is added to a maximal voluntary contraction (MVC), the difference in force output can provide a 
quantitative value of central activation. One method of calculating this deficit is the central activation ratio 
(CAR = MVC/(MVC + stimulated force))18. The purpose of this study was to collect pilot data that 
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quantified the neurological deficiencies in persons with PD and observe the sources of reduced strength in 
this population and establish a protocol for future studies.   
METHODS 
Subjects 
 Thirteen men (n = 10) and women (n = 3) were recruited to participate in the study. The seven 
persons in the PD group (M=6, F=7) were diagnosed with idiopathic PD. Individuals with orthostatic 
hypotension, dementia (Mini-Mental State Examination Scores <24), or other significant co-morbidities 
(i.e., stroke, severe degenerative osteoarthritis) were not recruited into the study. Further, great care was 
taken to exclude individuals with other causes of Parkinsonism such as progressive supranuclear palsy, 
vascular PD, and multiple system atrophy. A board-certified neurologist rated each PD subject according to 
the Unified Parkinson’s Disease Rating Scale (UPDRS) close to the time of testing. 
 Six neurologically healthy, age-similar individuals (M=4, F=2) were recruited from the local 
university faculty and staff for the control group. These subjects were of good general health based on self 
report and had no abnormal neurological diagnoses. All subjects completed a health history, drug usage, 
and fitness activity questionnaire, and provided written informed consent prior to data collection (see Table 
1). All testing was approved by the university institutional review board for human subjects research.  
 
 
Table 1. Descriptive Statistics 
 PD (n = 7) CONTROL (n = 6) 
Gender M = 6, W = 1 M = 4, W = 2 
Age (yr) 65.4±7.3 60.5±4.9 
Height (cm) 177.7±8.7 174.6±6.8 
Weight (kg) 84.9±6.5 81.1±14.2 
Thigh Circumference (cm) 52.6±5.4 52.9±5.1 
Thigh Skin Fold (mm) 22.6±11.1 25.5±15.8 
Thigh Cross-sectional Area (cm2) 56.3±19.7 59.3±7.8 
Maximum Voltage (mV) 283.3±25.8 271.4±56.7 
UPDRS 15.7±5.0 N/A 
Hoehn and Yahr Staging HY1.5, n=1; HY2, n=6 N/A 







 Upon arrival to the laboratory, subjects filled out a health history, medication, and fitness activity 
questionnaire after providing written informed consent. Additionally, investigators verbally obtained 
informed consent and answered any questions subjects had pertaining to the study. Subjects’ height and 
weight as well as thigh skinfold and circumference were measured (right leg). Skinfold and circumference 
were used to calculate quadriceps femoris cross-sectional area (CSA) according to the equation by Housh et 
al.19 ([2.52 x mid-thigh circumference in cm] – [1.25 x anterior thigh skinfold in mm] – 45.13). Pairs of 
round Ag-AgCl surface electrodes (Ambu Blue Sensor SP, 20 mm interelectrode distance) were affixed on 
the biceps femoris, vastus lateralis, and rectus femoris according to SENIAM guidelines20, with a ground 
electrode placed on the patella. Vastus medialis electrodes were placed just proximal to the anode of the 
stimulating electrode pair. Electrodes were placed parallel to the relaxed pennation angle of each muscle 
and had an inter electrode distance of 30 mm. Prior to electrode placement, skin was shaved, vigorously 
abraded, and cleaned with alcohol.  EMG was recorded during every trial using Myopac Jr (RUN 
Technologies; Mission Viejo, CA) with four dual-lead channels.  This system has a common mode 
rejection of 90 dB, a band-pass filter (10-1000 Hz), and input impedance of 10 MΩ.  Data were collected at 
1 kHZ and synchronized with the force signal. The EMG electrode leads were connected to a channel 
amplifier/encoder/fiber optic transmitter (Myopac Jr, Run Technologies) to obtain EMG signals, which 
were acquired via analog/digital conversion (Measurement Computing) at a sampling rate of 1000Hz 
utilizing Datapac5 software for processing and analysis. 
The subjects were seated in a customized chair which provided back support and placed the 
subject in an upright position21. Seatbelt restraints were placed across the subject’s trunk and lap to 
minimize movement of the torso17,21-24. Rubber stimulating electrodes (7.5 x 13 cm) were secured with tape 
over the femoral triangle (cathode) and just above the superior border of the patella (anode)14,17,21,22,25-28. 
The subject’s right ankle (all subjects were right-leg dominant) was inserted into a padded sleeve and cuff, 
and attached to the load cell (Transducer Techniques® MLP-1K load cell) with enough tension to eliminate 




Subjects were instructed to cross their arms over their chest during testing. For the first trial, 
subjects were asked to relax prior to being given a 200µs16 triplet pulse of 50mA at 400v29 (Digitmer® 
DS7AH) to the quadriceps14. The amperage was then increased in 50mA increments for subsequent trials16 
until the peak force reached a plateau (less than 5% change15), which was expected to occur between 200-
400mA23,30,31. An octet pulse was administered at the parameters that caused plateau in force to identify 
MIRFD30. Subjects were given as much time as they needed between twitches, which was less than one 
minute14,15. 
The subject was then instructed to maximally contract the quadriceps of their restrained leg to 
familiarize the feeling of performing MVCs. Two MVCs were performed with one minute rest between 
trials or when subject was ready to continue (see Fig. 2). The investigators then repeated the instructions for 
the MVC, and the subject was asked to perform a MVC where the predetermined triplet pulse (same 
maximal parameters) was applied during the plateau phase14,16,30,32. The MVC with stimulation trial was 
repeated twice25, with a minute break between each repetition, or until the subject was ready to continue. 
The better of two trials was used for analysis. Reliability of this protocol has been previously established in 
the literature17,33,34. 
Force signals were acquired via analog/digital conversion (Measurement Computing) utilizing 
Datapac5 software for both acquisition and processing. The force signal was filtered through a fourth-order 
Butterworth low-pass filter with a cutoff frequency of 30Hz.  The maximal RFD during electrically 
stimulated (MIRFD) and MVC (MVRFD) were calculated as the maximum velocity of the signal (N/s) 
during the rise phase.  Start of the action was defined as the point at which the first derivative of the filtered 
force signal crossed zero for the last time. The rate of force development ratio (RFDR) was calculated as 
the quotient of MVRFD divided by MIRFD. 
Statistics 
 Because of the pilot nature of this study, simple independent t-tests were used to compare MVF, 
seated isometric twitch force (SITF), MVRFD, MIRFD, CAR, RFDR, and rmsEMG between the groups. 
Effect sizes were calculated to determine the magnitude of differences between groups. Bivariate 





Eighteen subjects were brought in for testing, however, two did not finish the protocol due to 
discomfort and three of the subject’s data were not useable due to impact artifact in the force channel. We 
found significant differences between groups in MVRFD (PD = 2544.7N/s ± 1183.6, CTRL = 4598.9 ± 
1076.8; P = 0.008; see Fig. 3) and RFDR (PD = 0.45 ± 0.15, CTRL = 0.80 ± 0.20; P = 0.004; see Fig. 4), 
with the PD group having reduced scores compared to controls. No significant differences were found 
between groups for all other notable variables, including MIRFD (PD = 6145.2N/s ± 2641.3, CTRL = 
5836.8N/s ± 959.7; P = 0.79; see Fig. 5), SITF (PD = 697.6N ± 86.4, CTRL = 679.2N ± 108.2; P = 0.74; 
see Fig. 6), MVF (PD = 690.7N ± 85.2, CTRL = 665.9N ± 98.1; P = 0.64; see Fig. 7), and CAR (PD = 0.99 
± 0.03, CTRL = 0.98 ± .03; P = 0.63; see Fig. 8). There was no difference in voluntary activation 
(rmsEMG; Fig. 9) of the biceps femoris (PD = 209.97mV ± 50.6, CTRL = 275.59mV ± 128.3; P = 0.24), 
vastus lateralis (PD = 238.52mV ± 90.4, CTRL = 259.66mV ± 142.0; P = 0.75), rectus femoris (PD = 
147.51mV ± 95.0, CTRL = 178.0mV ± 78.1; P = 0.95), and vastus medialis (PD = 187.27mV ± 70.8, 
CTRL = 213.74mV ± 95.9; P = 0.60). Large effect sizes were found for RFDR (d = 2.03), biceps femoris 
rmsEMG (d = 1.84), and MVRFD (d = 1.82). 
DISCUSSION 
 This is the first investigation using PES to determine involuntary neuromuscular activation in PD. 
We have employed a PES protocol that has been established in other populations, but is novel in PD. We 
observed significant deficits in the PD group’s MVRFD and RFDR of the quadriceps femoris (QF) 
compared to healthy, similar age controls. Because the intent of this study was to collect pilot data, the 
sample size was small, and may be a limitation to our findings. This, paired with the high level of 
functioning of the subjects could have affected the overall results of the study—in particular the strength 
(MVF) measures. It should be noted that small effect sizes were noted in cases of no significant difference 
between groups. 
 As PD progresses, bradykinesia is commonly a troublesome symptom which adds to the difficulty 
of activities of daily living (ADL). Because MIRFD was similar for PD and controls, the mechanisms 
responsible for this deficit early in the disease appear to be purely central in nature. The PES-induced 
activation of the QF demonstrates the peripheral ability of the muscles to function, but the individuals with 
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PD were unable to actively replicate the voluntary RFD of healthy controls. Other investigations of strength 
measures reported similar findings of reduced voluntary RFD in persons with PD4,7,10, but this is the first to 
examine MIRFD in evoked contractions. Corcos et al.7 found a correlation between maximal strength and 
RFD and Allen et al.35 found similar deficits, reporting decreased leg strength and power (force x velocity) 
in PD compared to controls, whereas our results only suggest a difference in RFD. Allen et al.36 also 
investigated the relationship between reduced muscle power, slower walking velocity, and falling in PD, 
reporting that muscle power, compared to muscle strength, greatly affected walking velocity, and had 
stronger associations to falling than muscle strength alone. This indicates that the rate (velocity) at which 
force can be produced is as important as the force of muscle contraction36, and both should be considered 
when designing training protocols. 
Initial strength improvements consequent to resistance training appear to be largely accounted for 
by neural adaptations37. Del Olmo et al.38 specifically reported an adaptation in the central nervous system 
following resistance training, and confirmed the sustainability of this adaption with chronic training. 
Carroll et al.39 found similar results, and proposed that resistance training alters the organization of the 
central nervous system so that a given magnitude of corticospinal input activates fewer  motoneurons 
during muscle contraction than were recruited prior to training, and the maximal voluntary force is 
greater38.  
To date no PD resistance training studies have specifically trained (and tested) subjects with the 
objective of increasing RFD. Schilling et al.8 did instruct the subjects to “lift the weight as fast as possible 
with good form”, which has not been emphasized in the other literature to date. The literature on the effects 
of resistance training on RFD in healthy populations proposes that RFD is trainable over time40,41, but 
emphasizes the importance of the intent of moving the load quickly. Behm and Sale40 indicated that RFD 
can be increased by trying to move rapidly when moving heavy loads, in which case the actual velocity of 
the movement would be slow. This seems to correspond well with training prescriptions for improving 
maximal strength as well (high weight, moderate repetition). Also, instruction for the desired movement 




The PD group’s CAR scores and peak force measures were similar to the control group, even 
when adjusted for QF CSA. Full activation of the QF has been reported by several studies30,43-45, so the 
CARs being nearly 100% in the controls was not unfounded. As strength deficits were expected in this 
investigation, CAR scores for PD were also expected to be lower than controls, but the lack of differences 
in MVF may have translated to no differences in CAR. Also, our findings did not suggest reduced strength 
in the PD group, although several studies have reported decreased strength in persons with PD compared to 
controls4-13. Our hypothesis included similar strength deficits, but it is possible that our findings are a result 
of the PD group having only mild to moderate PD (UPDRS = 15.7 ± 5.0; H&Y = 1.9 ± 0.20) and minimal 
presence of symptoms when optimally medicated (as they were during testing). While our results did not 
agree with previous investigations for these strength variables, the literature has considerable agreement 
that reduced strength is a symptom of PD and this implies the value of resistance training interventions for 
this population1,46. 
Several resistance training studies have revealed increases in strength in persons with PD 
following 8-12 weeks of training8,47-51. Despite considerable differences in mode, intensity, volume, and 
frequency of resistance training in this population, all studies have reported increases in strength indices, 
which is promising. Still, the optimal resistance prescription has yet to be identified, and none of the 
aforementioned studies used RFD as an outcome measure. This prescription should specify the 
aforementioned training variables for persons with PD and indicate appropriate progression of training to 
optimize benefits and minimize fatigue.  
 Percutaneous electrical stimulation could enable quantitative measures of involuntary activation 
for the manipulation of numerous variables ranging from medication dose to the effects of exercise and 
physical therapy training programs. This pilot study identifies the efficacy of the PES protocol as an 
evaluation method for quantifying central versus peripheral neuromuscular RFD deficits in persons with 
PD. Using PES for pre- and post-testing in training interventions would establish a quantitative assessment 
for evaluating training protocols for persons with PD. This is especially critical in a time when exercise is 
becoming a more commonly investigated supplemental therapy for managing the progression and 
symptoms of the disease, and the optimal exercise prescription has yet to be found. Our investigation used 
PES to quantify QF activation (CAR), maximal strength (MVF), RFD (MVRFD and MIRFD), and RFDR. 
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The PD subjects had decreased MVRFD and RFDR, as they were unable to voluntarily produce force at the 
same rate as age-similar, healthy controls. We did not find significant differences in MVF, despite reports 
of this deficit in the current literature, which we attribute to a combination of small sample size and high 
function of the PD subjects. As investigations of exercise interventions are being proposed more frequently, 
a quantitative evaluation protocol, compared to qualitative testing and questionnaires, such as PES would 
be most advantageous for providing consistent comparisons among individual subjects and intervention 
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Fig. 3. Maximal voluntary rate of force development (Mean ± SD) for PD (2544.7N/s ± 1183.6) and CNTL 




Fig. 4. Rate of force development ratio (Mean ± SD) for PD (0.4 5± 0.15) and CNTL (0.80 ± 0.20). 




Fig. 5. Maximal involuntary rate of force development (Mean ± SD) for PD (6145.2N/s ± 2641.3) and 




Fig. 6. Maximal involuntary force (Mean ± SD) for PD (697.57N ± 86.4) and CNTL (679.2N ± 108.2). No 





Fig. 7. Maximal voluntary force (Mean ± SD) for PD (690N ± 58.2) and CNTL (655.9N ± 98.1). No 





Fig. 8. Central activation ratio (Mean ± SD) for PD (0.99 ± 0.03) and CNTL (0.98 ± 0.03). No significant 
difference was noted between groups (P = 0.634, d = 0.27) 
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Appendix A – Extended Literature Review 
Resistance training places significant amounts of stress on the muscles involved in the training 
program. As a result, many physiological adaptations occur within the body in response to the new 
demands placed on the muscles. The initial changes in strength are due to neurological adaptations that 
occur both at the muscle and peripheral nervous system as well as in the brain and spinal cord (central 
nervous system). The most effective evaluation method of the activity within the muscle is through 
superimposed electrical stimulation. When the muscle is relaxed, an electrically evoked, involuntary 
contraction can be used to estimate the capacity of the muscle’s contractility. If the subject voluntarily 
maximally contracts the muscle and an electrical stimulus is added to that, central activation deficiencies 
can be measured. If no additional recruitment is noted, the subject is able to maximally recruit that 
musculature. 
Although an abundance of studies have evaluated the methods of evoked contractions, only a 
small number of those have investigated neurological changes that occur as a result of resistance training. 
Consistent baseline measures have become available through testing healthy subjects, and new research can 
now be conducted to examine specific aspects of the neurological maladaptations taking place due to 
disease. With sufficient review, this may become an innovative tool for evaluating special populations such 
as those with neuromuscular disorders. 
ELECTRIC STIMULATION AS TECHNIQUE FOR MEASUREMENT 
Interpolated Twitch 
When determining levels of activation within the muscles, one of the most common techniques is 
superimposing electrical stimulation (ES) on the target muscle or the nerve that innervates the targeted 
muscle. The goal of the interpolated twitch technique (ITT) is to stimulate the nerve innervating the 
targeted muscle to determine the percentage of the muscle that can be recruited involuntarily. ITT identifies 
the difference between activation of the muscle with superimposed twitch at rest and activation of the 
muscle during maximal voluntary contraction (MVC) with the same superimposed twitch1,2. Motor unit 
(MU) activation has been evaluated in many studies using two methods which include ITT torque and the 
central activation ratio (CAR). ITT torque is reported as the amplitude in the force from the supramaximal 
twitch, whereas CAR is the ratio of ITT torque to the maximal voluntary torque level that immediately 
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preceded the delivery of the supramaximal stimulus 3. When compared to the CAR method, ITT torque 
resulted in higher sensitivity to joint-angle changes and decreased sensitivity to changes in number of 
stimuli2. 
Effect on different muscles 
Each muscle within the human body has its own specific make-up of MU and filaments in order to 
most efficiently carry out specialized movements. Also, despite systematic activation of MUs according to 
Henneman’s size principle, the areas of the muscle are recruited at random due to the distribution of the 
MU fibers in the cross-section of the muscle. Thus, several muscles and muscle groups have produced 
different responses to ITT. The most commonly studied have been the adductor pollicis, biceps brachii, 
triceps surae (gastrocnemius and soleus), and quadriceps femoris, in addition to the tibialis anterior. 
According to some studies4,5 not all of these muscles are able to be fully activated voluntarily, while others 
have consistently reported that the quadriceps femoris are typically capable of achieving maximal 
activation1,6. The differences in these findings are dependent on several variables including stimulation 
technique, location of stimulation, and intensity of stimulation. Specifically, converse outcomes have been 
reported when describing results using the percutaneous superimposed electrical stimulation technique 
(stimulating the muscle belly) versus the interpolated twitch technique (stimulating the muscle nerve). 
Also, the discrepancies in the maximal performance of the muscles could be due to differing distributions 
of fiber types within each individual muscle 5.  
Variables measured 
When assessing data from the ITT, several variables are available to measure and report. Among 
these are resting twitch torque, which can be measured using an isokinetic/isometric dynamometer or a 
force transducer 3. Maximal voluntary torque is reported using the same protocol as previously described, 
but is measured during MVC versus at rest with an involuntary contraction. Either measure of maximal 
evoked torque (resting or voluntary) involves percutaneous stimulation of the muscle which is particularly 
uncomfortable for the instant the stimulus is applied. Maximal rate of torque development is the change in 
force over the change in time. CAR is the ratio of MVC to total torque. Also, maximal firing rate was 
reported in several studies, referring to assessment of maximal motor unit action potentials which were 
measured using a needle electrode placed within the muscle belly 3. The torque time integral is typically 
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measured at 40ms (TTI40). The TTI40 is the area under the curve on the torque-time graph from 0-40 
seconds. The results of this variable are noteworthy Lastly, force has often been reported as absolute and 
relative rate of force development and maximal voluntary force (MVF). 
Variables concerning special populations 
Presently, all known studies using the ITT have used healthy subjects for their research. Although 
there have been studies that have evaluated fatigued muscles and musculoskeletal injuries, none to date 
have reported the use of ITT on special populations. Bampouras et al.2 and Kendall et al 7 suggested that 
when neural activation is accurately assessed during maximal efforts, new studies could evaluate the extent 
of neurological damage causing inactivation of skeletal muscles due to neuromuscular diseases2,7.  
Variance between men and women 
Although many studies have included both men and women in their investigations involving 
interpolated twitch and related stimulation techniques, there are few reports on gender differences. A study 
by Kramer 8  included findings of trends which suggested differences in the results of men and women. His 
explanations for variation included different proportions of large muscle fibers and distinction in sensitivity 
via cutaneous impedance 8. Additionally, Maffiuletti et al 9 reported that women had a lower sensory 
threshold than men and required lower amplitude of stimuli to achieve supramotor threshold. The data 
collected in this study suggested that women have a higher sensory and supramotor excitability to 
cutaneous electrical stimulation 9. 
Muscles stimulated 
As protocols and technology for electrical stimulation have evolved over the last two decades, four 
muscles have been studied extensively, including the adductor pollicis, biceps brachii, triceps surae, and 
quadriceps femoris. Because the adductor pollicis is a small muscle with limited surface area to stimulate, 
investigators have primarily used the ulnar nerve as opposed to the muscle belly. Cannon and Cafarelli 10, 
Herbert and Gandevia 11, and Bigland-Ritchie et al.12 followed similar methods by restraining the arm with 
the palm facing medially and placed the electrode directly over the ulnar nerve on the distal anterior side of 
the forearm. 
The biceps brachii is near optimal length for force production when the elbow is flexed at 90°. As 
a result, most investigators 1,4,13 use an apparatus to fix the arm in this position. The electrodes are then 
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placed over the motor point of the biceps brachii midway between the bicipital groove and the elbow crease 
and the distal biceps tendon 1,13. Behm et al.4 used slightly different placement of the distal electrode, 
securing it to the proximal, anterior portion of the forearm flexors. 
The triceps surae have been evaluated using two, slightly different placements of the electrodes, 
depending on which particular muscles the investigators were trying to stimulate. When exciting the triceps 
surae as a group, the tibial nerve is typically the target for stimulation. The electrodes are therefore placed 
in the popliteal fossa and at the distal triceps surae where it intersects the tendon 4,6,14. Aagaard et al.15 and 
Bigland-Ritchie et al.12 focused specifically on activation of the soleus, and placed one of the electrodes 
just distal to the gastrocnemius. The other electrode was placed either ~13cm proximal to the calcaneous15 
or over the Achilles’ tendon at the malleolus12. 
The quadriceps femoris have been extensively investigated using electrical stimulation. Since this 
muscle group is involved in activities such as rising from a chair and locomotion, activation is of prime 
importance. Many studies have used the percutaneous superimposed electrical stimulation technique (PES) 
to activate the quadriceps by stimulating the muscle bellies of the anterior thigh. Electrode placement for 
this technique has been reported without specific detail, or at similar, but slightly varying positions of the 
proximal and distal anterior thigh2-4,6,7,9,16-20. Dudley et al 17 and Kendall et al 7 placed 4.1 x 8.8-cm and 8 x 
10-cm electrodes (respectively) distally over the vastus medialis and the proximally over the vastus 
lateralis. Additionally, studies have been investigated using the ITT to stimulate the quadriceps. In this 
case, the femoral nerve was stimulated with the cathode over the femoral triangle above the femoral nerve 
and the anode placed transversely over the gluteal fold 21,22. 
Interpolated Twitch Technique v. Percutaneous Superimposed Electrical Stimulation Technique 
Over many years of critical analysis of superimposed electrical stimulation methods, two 
techniques have become generally accepted for producing reliable results. While both techniques are able 
to activate the muscle, variation occurs in the location of stimulation.  The ITT activates the muscle by 
stimulating the motor units with a twitch applied to the muscle nerve, whereas with the PES, the muscle is 
stimulated by electrodes placed directly on the muscle belly. Paillard et al 5noted the greatest drawback of 
the superimposed technique is the high level of pain that is inflicted with the electrical stimulation; if the 
stimulation of the muscle is too great, this could result in activation of the antagonist muscles. Paillard 
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concluded through analysis of the available literature that ITT was used most often for evaluation purposes 
while the PES was typically applied in training programs 5. 
Muscle action 
There seems to be little or no influence of each muscles said actions (flexion or extension) 
affecting the results of activation when measured using interpolated twitch. The biceps brachii are flexors 
of the arm, the quadriceps femoris are extensors of the knee, and the adductor pollicis muscle in the hand 
adducts the thumb; all three muscles (muscle groups) have been described as capable of full activation1,12. 
In contrast, Behm et al.6 suggested that when comparing the dorsiflexors of the foot with the plantar 
flexors, the dorsiflexors had a greater capacity to achieve full activation. It can be inferred that while there 
are a number of muscles that reportedly cannot voluntarily reach full activation, there is no apparent 
correlation between the action of the muscle and its ability to do so. 
ITT parameters: intensity, frequency, timing, and number of stimulation  
       The variables of percutaneous electrical stimulation delivered during ITT have been greatly varied 
between studies. The intensity of the stimuli is measured in volts (v), and milliamps (mA). Reports of these 
measures have ranged from 100-400v at 10mA-1A. The frequencies of stimulation vary between 10-
100Hz. Generally, 200-300µs pulses are administered 10-2000µs apart. The number of stimuli has ranged 
from single tetanus to octets. 
PHYSIOLOGY 
Different muscles 
The proportion of fiber types within each muscle and the elastic characteristics of its tendons seem 
to have a great impact on the muscle’s ability to reach full activation with voluntary contractions 5. 
According to Henneman’s size principle, MU will be recruited from smallest to largest in relationship to 
the intensity of stimulation applied. Fast twitch fibers are able to produce more force at a faster rate than 
slow oxidative fibers. As a result, if the muscle is maximally stimulated, whether voluntarily or 
involuntarily, muscles that have a greater percentage of fast twitch fibers (more fast twitch MU), have an 
increased opportunity for maximal activation. Behm et al.4 concluded that dorsiflexors of the foot have a 




Support for ability to increase MVC 
The amplitude of MVC depends on several factors that together affect the performance of the 
muscle. MVCs are directly related to α-motoneuron excitability, neural drive, MU recruitment, and 
motoneuron firing frequencies, among other things. Without optimal levels of all these elements, the 
muscle can still establish a contraction, however, when these variables increase, it directly results in an 
increase in MVC.  While hypertrophy (increase in cross-sectional area of the muscle) typically has a 
positive relationship with strength, hypertrophy doesn’t correlate with increases in MVC, as these increases 
typically occur as a result of central and peripheral neural adaptations15. 
Different muscle actions 
Several muscles have been studied with various types of electrical stimulation attempting to find 
the most accurate and reliable way to measure the contractility of the muscles. One of the variables in these 
investigations is the action being completed by the muscle while measurements are collected. According to 
Paillard et al 5, activation levels of each muscle are strongly influenced by the muscle action performed 
during testing. Overall, studies with healthy subjects who performed isometric contractions generally 
reported similar peak torque scores during voluntary and evoked contractions. PES trials requiring 
concentric muscle contractions during evaluation produced comparable or lesser peak torque values than 
voluntary contractions. In comparison, few studies have examined torque with eccentric muscle actions. 
However, some studies have suggested that voluntary actions will either be limited or improved due to 
neural protection of the muscles through mechanisms such as the golgi tendon organs (GTO), muscle 
spindles, and coactivation. Nonetheless, superimposed electrical stimulation creates physiological effects 
which are directly related to the mode of muscle action 5.  
Healthy subjects 
The results of many prior studies using superimposed electrical stimulation have been collected 
from healthy subjects1,2,7,9,12-16,18-25. These findings, while some are still inconclusive, are estimates of the 
musculoskeletal system’s maximal physiological capacity. Because the subjects were reportedly healthy 
during participation, inferences can be made about trends and could provide critical baseline measures for 





To date, few studies have explored PES or ITT methods to evaluate special populations. 
Specifically, physiological changes evolve with the onset and progression of neurological disorders which 
could be assessed and monitored using healthy subjects’ measures to establish a baseline. Because of 
reliability deficiencies in methods used in the past, electrical stimulation has not yet been used for this 
purpose2,7. There are several movement disorders that degenerate or alter central activation of motor 
control. Parkinson’s Disease, Progressive Supranuclear Palsy, and Huntington’s Disease, just to name a 
few, could all use the superimposed technique to monitor progression of the disease or progress in 
counteracting the disease as well as to measure degeneration of muscle activation capabilities. 
ADAPTATIONS TO RESISTANCE TRAINING 
Increased maximal voluntary activation 
As it has been well established in the literature, resistance training triggers an increase in strength 
of the involved muscles. In fact, the initial onset of the increase has been determined to be the result of 
neural adaptations, not physiological adaptations (hypertrophy) of the muscle itself. Some studies have 
assessed muscle activation in terms of this adaptive response and have found that resistance training 
increases levels of activation as well as maximal motor unit firing rate, although there was a weak 
correlation between the two variables 3. 
Aagaard et al.15 investigated amplitudes of the V-wave in pre- and post-14 wk resistance training 
regimens. When supramaximal nerve stimulation is applied during MVC, the efferent motor impulses 
generated because of activation of motoneurons via central descending pathways will collide with the 
antidromic potentials, thus allowing a part of the evoked reflex response to pass to the muscle, called the V-
wave. It’s been termed the V-wave to indicate its presence during voluntary efforts, but not at rest15. 
The subjects were put through a progressive heavy-resistance strength training program which 
resulted in elevated V-wave amplitudes, indicating neurological adaptations at spinal and supraspinal 
levels. The study identifies the possibility that these neural changes could implicate transformations in α-
motoneuron excitability and descending motor drive. The increased amplitude of the V-wave in response to 
resistance training is indicative of amplified neural drive in descending corticospinal pathways which is 
paralleled by an increase in motor neuron excitability. The study reports as much as 49% increases in V-
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wave amplitude in response to 9-21 wk of heavy-resistance strength training. The investigators suggest that 
this increase is the consequence of increases in motoneuron firing frequency and/or motoneuron 
recruitment. The conclusion that heavy-resistance strength training initiates a considerable increase in 
efferent motor output during MVC suggests that further studies should be done to investigate the this 
positive outcome15. 
Dynamic versus isometric testing 
Typically, to measure activation within a muscle through isometric contraction the evoked 
response is calculated by finding the difference between the peak force (PF) following MVC plus 
superimposed twitch and the PF of MVC. This approach is fairly straightforward and reliable when testing 
multiple sessions and has been frequently used. When testing with dynamic actions such as concentric 
contractions, force trace preceding stimulation is inferred to suggest an approximation of what the 
voluntary force would have been when evoked force reaches its peak 26. These numbers are somewhat 
arbitrary and this method has produced a negligible effect on estimations of voluntary activation when 
applied to isometric contractions1. Although isometric testing is less specific to dynamic training, the 
method of estimating voluntary activation of the muscle isometrically is far more accurate than testing with 
dynamic exercises. 
Increased maximal rate of force development (MRFD) 
When rationalizing an increase in MRFD, several factors seem to play a role in decreasing the 
amount of time required to reach maximal force. Aagaard et al.15 reported that following 14 wk of 
resistance training, the results suggested increases in efferent motor output, enhanced neural drive, and 
increased motoneuron excitability which produce increases in MVC. When more signals are sent with 
greater intensity to motoneurons which are increasingly accepting of the signals to stimulate the muscle, it 
seems logical that the muscle would respond by producing force at a faster rate. Although there will be an 
expected plateau at some point as the MRFD increases with resistance training, no longitudinal studies 
have been conducted to measure at what point this occurs. Further studies could investigate what 





Using PES in special populations: A case example of Parkinson’s Disease 
Parkinson’s Disease (PD) is a central nervous system (CNS) disorder that results in reduced 
strength 27among other disabling symptoms. Miscommunication within the nervous system of persons with 
PD first occurs deep within the brain, where the production of chemicals, called neurotransmitters, is 
altered by the disease. From there motor-control messages are encrypted with problems along the way, 
which result in either the message never reaching the muscle or the message being misrepresented by the 
time it gets there. Nallegowda et al 28 has demonstrated that strength deficits are at least partially central in 
nature, but techniques such as ITT and PES have not yet been used on this population.  
As a result of the impairment of neurological efficiency when a message relaying motor-control is 
sent from the brain to initiate a voluntary movement, an individual with PD would be expected to have 
decreased MVC. However, if the muscle were directly stimulated using ITT or PES, the involuntary 
activation should still be maximal because the PD has not been found to damage the peripheral nervous 
system.  Thus, persons with PD should have a reduced CAR, but this has yet to be determined. Also, PES 
may be able to give us more information about the adaptations in the CNS with strength training in persons 
with CNS disorders.  
CONCLUSIONS 
Due to the neuromuscular stress when an individual engages in resistance training, the body reacts 
quickly by adapting the neurological pathways for communication between the muscle and the central 
nervous system (spinal cord and brain), causing changes to occur both at the periphery and centrally. The 
neurological adaptations that take place can be identified and evaluated by methods including ITT and PES. 
Following decades of critical analysis of the techniques used to interpret muscle contractility and its 
relationship to the nervous system, general conclusions can be made regarding the ability to stimulate 
different muscles and the most reliable methods can be elucidated from the many methodologies that have 
already been explored. Studies have been conducted to measure these effects on healthy populations, but 
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